- Home
- FTHM vs CELU Comparison
FTHM vs CELU Comparison
Compare FTHM & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- CELU
- Stock Information
- Founded
- FTHM 2010
- CELU 2016
- Country
- FTHM United States
- CELU United States
- Employees
- FTHM N/A
- CELU N/A
- Industry
- FTHM Real Estate
- CELU Biotechnology: Pharmaceutical Preparations
- Sector
- FTHM Finance
- CELU Health Care
- Exchange
- FTHM Nasdaq
- CELU Nasdaq
- Market Cap
- FTHM 38.3M
- CELU 42.2M
- IPO Year
- FTHM 2020
- CELU N/A
- Fundamental
- Price
- FTHM $1.30
- CELU $3.53
- Analyst Decision
- FTHM Buy
- CELU
- Analyst Count
- FTHM 1
- CELU 0
- Target Price
- FTHM $2.50
- CELU N/A
- AVG Volume (30 Days)
- FTHM 150.0K
- CELU 183.5K
- Earning Date
- FTHM 08-12-2025
- CELU 05-08-2025
- Dividend Yield
- FTHM N/A
- CELU N/A
- EPS Growth
- FTHM N/A
- CELU N/A
- EPS
- FTHM N/A
- CELU N/A
- Revenue
- FTHM $390,032,000.00
- CELU $54,220,000.00
- Revenue This Year
- FTHM $32.40
- CELU $23.29
- Revenue Next Year
- FTHM $18.04
- CELU N/A
- P/E Ratio
- FTHM N/A
- CELU N/A
- Revenue Growth
- FTHM 19.16
- CELU 138.11
- 52 Week Low
- FTHM $0.65
- CELU $1.00
- 52 Week High
- FTHM $3.37
- CELU $5.22
- Technical
- Relative Strength Index (RSI)
- FTHM 50.06
- CELU 56.43
- Support Level
- FTHM $1.05
- CELU $3.03
- Resistance Level
- FTHM $1.50
- CELU $3.40
- Average True Range (ATR)
- FTHM 0.14
- CELU 0.21
- MACD
- FTHM 0.00
- CELU -0.05
- Stochastic Oscillator
- FTHM 35.71
- CELU 36.36
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.